No black box warning on record for Margenza

As of the latest FDA labeling reviewed, Margenza (MARGETUXIMAB-CMKB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Margenza medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infusion-Related Reactions (IRRs): Monitor for signs and symptoms. If a significant infusion-associated reaction occurs, slow or interrupt the infusion and administer appropriate medical therapies. ( 5.3 ) 5.1 Left Ventricular Dysfunction Left ventricular cardiac dysfunction can occur with MARGENZA. In SOPHIA, left ventricular dysfunction occurred in 1.9% of patients tre

No black box warning on record for Margenza

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infusion-Related Reactions (IRRs): Monitor for signs and symptoms. If a significant infusion-associated reaction occurs, slow or interrupt the infusion and administer appropriate medical therapies. ( 5.3 ) 5.1 Left Ventricular Dysfunction Left ventricular cardiac dysfunction can occur with MARGENZA. In SOPHIA, left ventricular dysfunction occurred in 1.9% of patients tre

Margenza Black Box Warning

No black box warning on record for Margenza

Other warnings & precautions

Margenza Black Box Warning

No black box warning on record for Margenza

Other warnings & precautions